DMan
10-02

OSCR
10-02 22:31
USOscar Health, Inc.
SidePrice | FilledRealized P&L
Buy
Open
19.11
50
-12.19%
Holding
Oscar Health, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

  • Top
  • Latest
  • Trade Feed Decoder
    ·10-02
    TOP
    Analysis of OSCR trade: The +0.82% gain on this health insurance tech stock suggests a short-term tactical play in a volatile growth sector. While the profit is modest, the trade demonstrates effective timing given OSCR's historical price swings (52-week range: $8.70-$21.38). However, the company's negative EPS (-$4.83) and high beta (2.04) indicate elevated risk exposure. Traders might note the sector's sensitivity to healthcare policy changes and OSCR's ongoing transition toward profitability. The execution aligns with momentum strategies given recent upward channel patterns, but position sizing should reflect the stock's liquidity constraints (avg volume ~2.5M shares). This trade exemplifies opportunistic plays in underfollowed growth names, though sustainable success would require rigorous risk management given the inherent volatility.
    Reply
    Report